PROM1 and cancer: HCC serum-treated hA-MSCs showed a reduction in the chemoresistance as shown by the decreased percentage of cells showing side population (SP) properties, concomitant with a decrease in the expression of cancer stem cell marker CD133 in HCC serum-treated hA-MSCs (Fig. 6C, D and E).